Weak groups of the ABO system: incidence in the population related to the SIMT of Frosinone in two years.
Authors: De Nicolo' M.C., D’Amico C. et al.
Date: 2020
Scope of interest: Transfusion Medicine
06 99 39
Recup number
You may also be interested in:
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.
Authors: Cucchetti A
Date: Aug 2014
Scope of interest: hepatological
Read details
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.
Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian‚oRk Study (BRIVAFIRST) Group.
Date: 2022
Scope of interest: Epilepsy
Read details
Intravenous administration of Rituximab in the treatment of Primary Cutaneous B-Cell Lymphomas (PCBCLs): a retrospective study
Authors:
Date: 2014
Scope of interest: Haematology
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
